The small molecule pharmaceutical market relies on advanced technologies and speed of delivery at all stages of program development from R&D through launch and commercial manufacturing supply.
In addition to both enzyme technology and synthetic technology developed by Kaneka over the last 5 decades, we have expanded our technology expertise to include both flow chemistry and polymorphism control. The combination of these technologies provides Kaneka with the tools to develop chemistry for a range of targets in collaboration with our customers, from research and development to commercial development. Please contact us to find out how these original Kaneka technologies could be applied to your new or existing process.

RSMs, GMP Intermediates, APIs

Technical capability

Optimal scale-up by process engineering technology (Production Technology Research Team)

Enzyme Technology

Screening, Original enzyme library

  • Enzymatic reaction
  • Enzyme engineering
  • Immobilization of Enzyme

Flow Technology

Various Services facilities

  • Multi phase reaction
  • Enzyme engineering
  • Specific reaction (photo, high temp.)

API Technology

Important factor of formulation

  • Polymorphism control
  • Particle size control